ProCE Banner Activity

Insights on the Management of Patients With Chronic Hepatitis B and Hepatitis Delta

Text Module

Review guidance from the AASLD, EASL, and APASL for monitoring and treating chronic hepatitis B and hepatitis delta viral infections.

Released: December 01, 2022

Expiration: November 30, 2023

No longer available for credit.

Share

Faculty

Maria Buti

Maria Buti, MD

Professor of Medicine
Senior Consultant
Hospital Universitario Valle Hebron
Barcelona, Spain

Paul Y. Kwo

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Grace LH Wong

Grace LH Wong, MD

Professor
Gastroenterology and Hepatology
Assistant Dean (Learning Experience)
Director
CUHK Medical Data Analytics Centre (MDAC)
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Partners

ALF

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Maria Buti, MD

Professor of Medicine
Senior Consultant
Hospital Universitario Valle Hebron
Barcelona, Spain

Maria Buti, MD: consultant: Gilead Sciences.

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Paul Y. Kwo, MD: consultant/advisor/speaker: Aligos, Antios, Assembly, Enanta, Gilead Sciences, Janssen; researcher: Bristol Myers Squibb, Eiger, Gilead Sciences, Janssen, Target Registries; grant support: Altimmune.

Grace LH Wong, MD

Professor
Gastroenterology and Hepatology
Assistant Dean (Learning Experience)
Director
CUHK Medical Data Analytics Centre (MDAC)
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China

Grace LH Wong, MD: consultant: AbbVie, Gilead Sciences, and Janssen.